JNJ vs ABBV
By Alex · Tickerpine
Johnson & Johnson vs AbbVie Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ABBV |
|---|---|---|
| Price | $254.66 | $253.35 |
| Market cap | $613.02B | $447.62B |
| P/E ratio | 29.5 | 123.6 |
| ROE | 26.42% | — |
| Profit margin | 21.83% | 5.79% |
| Revenue growth | 9.90% | 12.40% |
| Dividend yield | 2.10% | 2.73% |
| Beta | 0.26 | 0.31 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ABBV in plain English
- JNJ is the bigger company — about 1.4× the market cap of ABBV.
- JNJ is cheaper on earnings (P/E 29.5 vs 123.6).
- ABBV is growing revenue faster (12% vs 10%).
- ABBV has the higher dividend yield (2.73% vs 2.10%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.